GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Price-to-Funds-From-Operations

CERO (CERo Therapeutics Holdings) Price-to-Funds-From-Operations : (As of Apr. 08, 2025)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


CERo Therapeutics Holdings Business Description

Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, South San Francisco, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.